MarketInOut Stock Screener Log In | Sign Up

Australian Clinical Labs Ltd

Healthcare • Diagnostics & Research • Quote as of 10/29/2026 16:10
Australian Clinical Labs Ltd stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
Market Capitalization546.5 mln
Float156 mln
Earnings Date02/23/2027

EPS

0.12
Marginal

P / E

26.83
Elevated

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.67
Highly reliable

1-Year Forecast

2.79
Limited downside

Relative Strength

94 / 100
Top performer

Business Description

Australian Clinical Labs is an Australian pathology company that provides a broad range of diagnostic testing services to doctors, patients, and businesses. Its work spans cancer screening, genetic testing, pregnancy-related diagnostics, drug and alcohol testing, and specialist areas such as microbiology, immunology, and veterinary pathology. The company also supports clinical trials and offers professional development programs for healthcare practitioners. Founded in 2020 and based in Clayton, it operates as one of Australia's dedicated pathology providers.

Key Fundamentals

EPS0.12
P/E26.83
ROE15.09
RPS3.84
ROIC6.12
ROA4.11
Interest Cover3.18
EBITDA, mln191
EV / EBITDA4.45
EV / EBIT15.23
Revenue, mln730
EV / Revenue1.17

Quote Details

Last 3.24
Change 0.09 (2.86%)
Open 3.18
Volume 929,039
Turnover 3,010,086
Average Volume 414,978

Financial Ratios

Pre-Tax Profit Margin5
Leverage Ratio3.96
Current Ratio0.54
Price / Book3.52
Price / Cash Flow3.43
Price / Free Cash Flow3.58
Debt / Equity2.26
Price / Sales0.76

Financial Strength

Altman Z-Score2.45
Piotroski F-Score 4 / 9
Beneish M-Score-3.67
Price to Intrinsic Value0.33
1-Year Target Price2.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 10.96% 94 / 100   
1 Month 13.68% 95 / 100   
2 Months 42.69% 97 / 100   
6 Months 77.89% 98 / 100   
1 Year 31.24% 89 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog